I already know the news! Is trametinib covered by medical insurance?

As of January 2024, the original drug Trametinib has been launched in China and is included in the scope of medical insurance. Only patients who meet the indications can choose to reimburse, including melanoma, non-small cell lung cancer, etc. Eligible patients can enjoy the national medical insurance reimbursement policy when purchasing trametinib drugs in local hospitals and other places. Patients who do not meet the conditions can only purchase it at their own expense.

Trametinib is a drug used to treat cancer. After approval by the U.S. Food and Drug Administration (FDA), it can be used alone or in combination with dabrafenib to treat patients with cancers with specific BRAF mutations, such as melanoma and non-small cell lung cancer. Dabrafenib is also a BRAF inhibitor used to increase the effectiveness of treatment. Trametinib can induce apoptosis (or programmed cell death) and inhibit cell proliferation, both of which are important in the treatment of malignancies. Side effects include nausea, vomiting, diarrhea, fatigue, headache, high blood pressure, etc. These side effects usually disappear within a few weeks after treatment.

Common specifications of the domestically marketed trametinib original drugThe price of 2 mg*30 tablets of trametinib is more than RMB 10,000, while the price of the original trametinib drug sold overseas in the specification of 2 mg*30 tablets is more than RMB 7,000 (the price may fluctuate due to exchange rates). There are also generic trametinib drugs produced in other countries overseas, and their pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of 2mg*30 tablets produced by a Laos pharmaceutical factory is more than 2,000 yuan (the price may fluctuate due to the exchange rate), and the price is relatively cheap.